The Type 4 Prepilin Peptidases Comprise a Novel Family of Aspartic Acid Proteases*

Total Page:16

File Type:pdf, Size:1020Kb

The Type 4 Prepilin Peptidases Comprise a Novel Family of Aspartic Acid Proteases* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 2, Issue of January 14, pp. 1502–1510, 2000 © 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The Type 4 Prepilin Peptidases Comprise a Novel Family of Aspartic Acid Proteases* (Received for publication, August 13, 1999, and in revised form, October 29, 1999) Christian F. LaPointe‡ and Ronald K. Taylor§ From the Department of Microbiology, Dartmouth Medical School, Hanover, New Hampshire 03755 Type 4 prepilins or prepilin-like-proteins are secreted The related type 4 pilin-like proteins partially comprise the by a wide range of bacterial species and are required for main terminal branch of the general secretory pathway in a variety of functions including type 4 pilus formation, Gram-negative bacteria, also known as the type 2 secretion toxin and other enzyme secretion, gene transfer, and pathway (6). The general secretory pathway is the pathway biofilm formation. A distinctive feature of these proteins utilized by the majority of proteins that are secreted outside of is the presence of a specialized leader peptide that is Gram-negative bacteria. Such proteins include toxins such as cleaved off by a cognate membrane-bound type 4 prepi- cholera toxin of V. cholerae (7) and exotoxin A of Pseudomonas lin peptidase (TFPP) during the process of secretion. In aeruginosa (8), as well as other enzymes such as pullulanase of this report we show that the TFPPs represent a novel Klebsiella pneumoniae (9) and hemolysin of Aeromonas hy- family of bilobed aspartate proteases that is unlike any drophila (10). Type 4 pilin-like proteins are also required for other protease. The active site pairs of aspartic acids of the two TFPPs in Vibrio cholerae are found at positions natural transformation of Bacillus subtilus (11) and Strepto- 125 and 189 of TcpJ and 147 and 212 of VcpD. Corre- coccus pneumoniae (12). sponding aspartate residues are completely conserved The type 4 leader peptide is characterized by several features throughout this extensive peptidase family. that are highly conserved, yet differ from those of standard leader peptides. The N-terminal leader that is cleaved from the mature protein is highly charged and immediately precedes a Members of the family of leader peptidases known as type 4 region of approximately 20 residues that are predominantly prepilin peptidases (TFPP)1 have been identified in a vast hydrophobic and are retained within the mature protein. The number of species of Gram-negative bacteria and an increasing majority of type 4 prepilins or prepilin-like proteins are desig- number of Gram-positive bacteria. The TFPP is responsible for nated type 4a, containing leader peptides that are short (ϳ6 the cleavage and N-methylation (known collectively as process- residues). Type 4b preproteins contain a longer leader (ϳ25 ing) of the highly conserved type 4 leader peptide present at the residues). The peptide bond on the prepilin that is hydrolyzed N terminus of the families of secreted proteins known as type 4 by the TFPP lies between the charged and hydrophobic do- prepilins and type 4 prepilin-like proteins (1). Whereas the mains, immediately C-terminal to an invariant glycine. The cleavage of the type 4 leader peptide is a necessary step for new N-terminal amino acid that arises upon processing is a secretion of the mature pilin, methylation of the N terminus of N-methylated phenylalanine for type 4a proteins and is typi- the mature pilin is not required for secretion and has no known cally a N-methylated methionine for type 4b proteins. The function (2). Type 4 pilins are polymerized as the structural TFPPs themselves are integral cytoplasmic membrane proteins subunits of type 4 pili (Tfp), which are surface organelles re- with numerous transmembrane domains. The processing reac- quired for diverse activities that contribute to broad attributes tion has been postulated to occur on the cytoplasmic side of the such as genetic transfer, virulence, and environmental persist- membrane because of the membrane orientation of the prepi- ence of a wide array of Gram-negative bacterial pathogens. lin, the location of all the major nonmembrane peptidase do- Prototypical examples include microcolony formation mediated mains, and the likelihood that the cytoplasmically located S- by toxin-coregulated pilus (TCP) of Vibrio cholerae,2 bacterial adenosyl methionine would provide an available source of surface dispersal mechanisms mediated by bundle forming pi- methyl groups for the methylation step of the reaction (13). lus of enteropathogenic Escherichia coli (3), colonization and Previous studies on the proteolytic mechanism of the TFPPs natural transformation mediated by PilE of Neisseria sp. (4), have focused on the largest cytoplasmic region of the protein and gliding motility mediated by the Tfp of Myxococcus sp. (5). designated cytoplasmic domain 1. These studies were per- formed on PilD, a prototypic TFPP from P. aeruginosa. Domain * This work was supported in part by Grant ROI AI 23096 from the 1 of the PilD peptidase contains two pairs of cysteine residues National Institutes of Health. The costs of publication of this article that are conserved among many members of the TFPP family. were defrayed in part by the payment of page charges. This article must Alteration of the 4 highly conserved cysteine residues by sub- therefore be hereby marked “advertisement” in accordance with 18 stitution of alanine or serine residues resulted in up to an U.S.C. Section 1734 solely to indicate this fact. ‡ Recipient of Predoctoral Fellowship AI F31-09635 from the Na- 80–100% reduction of peptidase activity in an in vitro assay. tional Institutes of Health. However, the processing defect varied from approximately 0% § To whom correspondence should be addressed: Dept. of Microbiol- to 80% for the various mutants in vivo, suggesting that al- ogy, Dartmouth Medical School, Hanover, NH 03755. Tel.: 603-650- though pilin cleavage was less efficient, it was not abolished 1632; Fax: 603-650-1318; E-mail: [email protected]. 1 The abbreviations used are: TFPP, type 4 prepilin peptidase; Tfp, (14). Chemical inhibitor studies supported the notion that the type 4 pili; TCP, toxin-coregulated pilus; NEM, N-ethylmaleimide; cysteine residues contributed to protease activity and PilD was PCR, polymerase chain reaction; Ab, antibody; PAGE, polyacrylamide classified as a cysteine protease, specifically as a member of the gel electrophoresis; EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodi- C20 family of cysteine proteases (15). The retention of partial imide hydrochloride. 2 Kirn, T. J., Lafferty, M. L., Sandoe, C. M. P., and Taylor, R. K. activity by some of the pilD mutants as well as the subsequent (2000), Mol. Microbiol., in press. discovery of TFPP’s that lack the consensus cysteine residues 1502 This paper is available on line at http://www.jbc.org Protease Active Site of TFPP 1503 have brought this mechanism of protease activity into question. TcpA Prepilin—The method for membrane preparation was adapted For example, the XpsO TFPP of Xanthomonas campestris was from a previously described cell fractionation protocol (25). A 100-ml characterized and shown to lack all the domain 1 cysteine overnight culture was placed on ice for 20 min, and the cells were then collected by centrifugation at 5000 ϫ g for 10 min. The cell pellet was residues, yet the xpsO gene fully complements a pilD deletion resuspended in 1 ml of 200 mM Tris, pH 8.0, to which 1 ml of 50 mM Tris, for prepilin processing (16). Some newer members of the rap- ␮ ␮ pH 8.0, 1 M sucrose, 2 ml of H2O, 20 lof0.5M EDTA, and 20 lof idly growing family lack the entire domain 1 region. Analysis of lysozyme (10 mg/ml) were added. The cell suspension was allowed to ␮ a current TFPP alignment also reveals a complete lack of any incubate on ice for an additional 30 min. 100 lof1M MgSO4 was conserved histidine residue, a necessary component of the cys- added, and the suspension was centrifuged at 5000 ϫ g for 10 min. The ϫ teine protease catalytic mechanism (15). These observations cell pellet is resuspended in 5 ml of 50 mM Tris, pH 8.0, sonicated 3 15 s at 50% duty, and centrifuged at 5000 ϫ g for 10 min. The super- have led to a revised classification of PilD, and therefore the natant was then centrifuged at 230,000 ϫ g (60,000 rpm in a TLA 100.3 complete family of TFPPs, to the U12 category of proteases rotor) for 15 min. The resulting pellet, which contained the total mem- with unknown catalytic mechanism (17). brane fraction, was resuspended in 200 ␮lof50mM Tris, pH 8.0. In the study reported here, an approach similar to the com- TcpA Prepilin Quantitation—Membrane preparations were prepared prehensive mutational strategy employed to identify the signal from 42 °C grown overnight cultures of E. coli K38, which does not peptidase I active site (18) was used to determine the active site express TcpA, and MK90, which overexpresses TcpA prepilin at ele- vated temperature. 20 ␮l of a membrane preparation from K38 and residues of TcpJ, the TFPP responsible for processing the TcpA from MK90 were subjected to electrophoresis on a 12.5% SDS-PAGE gel type 4 prepilin of V. cholerae. A protein sequence alignment of alongside a standard of 3 ␮g of trypsin, followed by staining with the TFPP family revealed several highly conserved potential Coomassie Blue. The stained gel was dried using the Novex gel drying protease active site residues in addition to the two cysteine system. The dried gel was scanned by a Molecular Dynamics Personal pairs that exist in this protease family. These include serine, Densitometer SI, and densitometry analysis was performed using Im- aspartic acid, lysine, and glutamic acid residues, most of which ageQuant version 1.2 software.
Recommended publications
  • Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
    Journal of the American Heart Association ORIGINAL RESEARCH Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals Joonatan Palmu , MD; Aaro Salosensaari , MSc; Aki S. Havulinna , DSc (Tech); Susan Cheng , MD, MPH; Michael Inouye, PhD; Mohit Jain, MD, PhD; Rodolfo A. Salido , BSc; Karenina Sanders , BSc; Caitriona Brennan, BSc; Gregory C. Humphrey, BSc; Jon G. Sanders , PhD; Erkki Vartiainen , MD, PhD; Tiina Laatikainen , MD, PhD; Pekka Jousilahti, MD, PhD; Veikko Salomaa , MD, PhD; Rob Knight , PhD; Leo Lahti , DSc (Tech); Teemu J. Niiranen , MD, PhD BACKGROUND: Several small-scale animal studies have suggested that gut microbiota and blood pressure (BP) are linked. However, results from human studies remain scarce and conflicting. We wanted to elucidate the multivariable-adjusted as- sociation between gut metagenome and BP in a large, representative, well-phenotyped population sample. We performed a focused analysis to examine the previously reported inverse associations between sodium intake and Lactobacillus abun- dance and between Lactobacillus abundance and BP. METHODS AND RESULTS: We studied a population sample of 6953 Finns aged 25 to 74 years (mean age, 49.2±12.9 years; 54.9% women). The participants underwent a health examination, which included BP measurement, stool collection, and 24-hour urine sampling (N=829). Gut microbiota was analyzed using shallow shotgun metagenome sequencing. In age- and sex-adjusted models, the α (within-sample) and β (between-sample) diversities of taxonomic composition were strongly re- lated to BP indexes (P<0.001 for most). In multivariable-adjusted models, β diversity was only associated with diastolic BP (P=0.032).
    [Show full text]
  • Structural and Biochemical Characterizations of Three Potential Drug Targets from Pathogens
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 2020 Structural and Biochemical Characterizations of Three Potential Drug Targets from Pathogens LU LU ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6214 ISBN 978-91-513-1148-7 UPPSALA urn:nbn:se:uu:diva-435815 2021 Dissertation presented at Uppsala University to be publicly examined in Room A1:111a, BMC, Husargatan 3, Uppsala, Friday, 16 April 2021 at 13:15 for the degree of Doctor of Philosophy. The examination will be conducted in English. Faculty examiner: Christian Cambillau. Abstract Lu, L. 2021. Structural and Biochemical Characterizations of Three Potential Drug Targets from Pathogens. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 2020. 91 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-1148-7. As antibiotic resistance of various pathogens emerged globally, the need for new effective drugs with novel modes of action became urgent. In this thesis, we focus on infectious diseases, e.g. tuberculosis, malaria, and nosocomial infections, and the corresponding causative pathogens, Mycobacterium tuberculosis, Plasmodium falciparum, and the Gram-negative ESKAPE pathogens that underlie so many healthcare-acquired diseases. Following the same- target-other-pathogen (STOP) strategy, we attempted to comprehensively explore the properties of three promising drug targets. Signal peptidase I (SPase I), existing both in Gram-negative and Gram-positive bacteria, as well as in parasites, is vital for cell viability, due to its critical role in signal peptide cleavage, thus, protein maturation, and secreted protein transport. Three factors, comprising essentiality, a unique mode of action, and easy accessibility, make it an attractive drug target.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Jéssica Michelle Da Silveira Dalsuco
    2º CICLO MESTRADO EM FISIOPATOLOGIA CARDIOVASCULAR PERFIL DA EXPRESSÃO PROTEICA NA DOENÇA ARTERIAL CORONÁRIA E FATORES DE RISCO QUANDO ASSOCIADA À ESTENOSE AÓRTICA JÉSSICA MICHELLE DA SILVEIRA DALSUCO M 2019 ORIENTADOR: PROF. DR. ANTÓNIO DE SOUSA BARROS COORIENTADOR: PROF. DR. RUI MIGUEL PINHEIRO VITORINO 2 "Há verdadeiramente duas coisas diferentes: saber e crer que se sabe. A ciência consiste em saber, em crer que se sabe reside a ignorância" Hipócrates 3 4 Agradecimentos Ao Professor Doutor Adelino Leite Moreira, Coordenador do Mestrado em Fisiopatologia Cardiovascular e Diretor do Departamento de Cirurgia e Fisiologia do Centro de Investigação Médica da Faculdade de Medicina da Universidade do Porto, pela oportunidade que me foi concedida em ingressar neste mestrado e na realização desta dissertação. Ao meu orientador, Professor Doutor António Barros e, coorientador, Professor Doutor Rui Vitorino, pelo acompanhamento, disponibilidade, ensinamentos e apoio moral durante a realização da presente dissertação. À Professora Doutora Rita Ferreira pela disponibilidade no auxílio da parte experimental. À Doutora Francisca Saraiva e a sua equipe, pela paciência e apoio incondicional, desde o meu ingresso no mestrado até a realização da dissertação. Aos meus pais, Nasser e Sónia, a minha irmã, Yara e avó Rosa, a quem eu homenageio esta dissertação pois apesar da distância, mantiveram-se sempre presentes com o seu amor, carinho e motivação incondicional. Ao meu namorado, Míchel Tamele, pelo companheirismo, paciência, moral e todo o amor concedido durante estes anos. As minhas amigas, Jéssica Marina, Jéssica Paloma, Patrícia e Lousane, que sempre fizeram questão de estar presente em todas as fases, mesmo longe, e deram me forças para chegar até aqui.
    [Show full text]
  • Proteolytic Enzymes in Grass Pollen and Their Relationship to Allergenic Proteins
    Proteolytic Enzymes in Grass Pollen and their Relationship to Allergenic Proteins By Rohit G. Saldanha A thesis submitted in fulfilment of the requirements for the degree of Masters by Research Faculty of Medicine The University of New South Wales March 2005 TABLE OF CONTENTS TABLE OF CONTENTS 1 LIST OF FIGURES 6 LIST OF TABLES 8 LIST OF TABLES 8 ABBREVIATIONS 8 ACKNOWLEDGEMENTS 11 PUBLISHED WORK FROM THIS THESIS 12 ABSTRACT 13 1. ASTHMA AND SENSITISATION IN ALLERGIC DISEASES 14 1.1 Defining Asthma and its Clinical Presentation 14 1.2 Inflammatory Responses in Asthma 15 1.2.1 The Early Phase Response 15 1.2.2 The Late Phase Reaction 16 1.3 Effects of Airway Inflammation 16 1.3.1 Respiratory Epithelium 16 1.3.2 Airway Remodelling 17 1.4 Classification of Asthma 18 1.4.1 Extrinsic Asthma 19 1.4.2 Intrinsic Asthma 19 1.5 Prevalence of Asthma 20 1.6 Immunological Sensitisation 22 1.7 Antigen Presentation and development of T cell Responses. 22 1.8 Factors Influencing T cell Activation Responses 25 1.8.1 Co-Stimulatory Interactions 25 1.8.2 Cognate Cellular Interactions 26 1.8.3 Soluble Pro-inflammatory Factors 26 1.9 Intracellular Signalling Mechanisms Regulating T cell Differentiation 30 2 POLLEN ALLERGENS AND THEIR RELATIONSHIP TO PROTEOLYTIC ENZYMES 33 1 2.1 The Role of Pollen Allergens in Asthma 33 2.2 Environmental Factors influencing Pollen Exposure 33 2.3 Classification of Pollen Sources 35 2.3.1 Taxonomy of Pollen Sources 35 2.3.2 Cross-Reactivity between different Pollen Allergens 40 2.4 Classification of Pollen Allergens 41 2.4.1
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
    [Show full text]
  • Análise De Padrões De Interação Entre Serino Proteases E Seus Inibidores Protéicos
    UNIVERSIDADE FEDERAL DE MINAS GERAIS INSTITUTO DE CIÊNCIAS BIOLÓGICAS PROGRAMA DE PÓS-GRADUAÇÃO EM BIOINFORMÁTICA ANÁLISE DE PADRÕES DE INTERAÇÃO ENTRE SERINO PROTEASES E SEUS INIBIDORES PROTÉICOS Tese apresentada ao Curso de Pós- graduação em Bioinformática da Universidade Federal de Minas Gerais como requisito parcial para a obtenção do grau de Doutor em Bioinformática. CRISTINA RIBEIRO Orientador: Marcelo Matos Santoro Co-Orientador: Goran Neshich Belo Horizonte 08 de abril de 2009 UNIVERSIDADE FEDERAL DE MINAS GERAIS Folha de Aprovação Análise de Padrões de Interação entre Serino Proteases e seus Inibidores Protéicos CRISTINA RIBEIRO Tese defendida e aprovada pela banca examinadora constituída por Prof. Ph. D. MARCELO MATOS SANTORO – Orientador Universidade Federal de Minas Gerais Ph. D. GORAN NESHICH – Co-Orientador Empresa Brasileira de Pesquisa Agropecuária Prof. Ph. D. MONIQUE ARAÚJO DE BRITO Universidade Federal Fluminense Prof. Ph. D. CAIO JÚLIO MARTINS VELOSO Pontifícia Universidade Católica de Minas Gerais Prof. Ph. D. RONALDO ALVES PINTO NAGEM Universidade Federal de Minas Gerais Ph. D. HUMBERTO D’MUNIZ PEREIRA Universidade de São Paulo Belo Horizonte 08 de abril de 2009 ii “Matar o sonho é matarmo-nos. É mutilar a nossa alma. O sonho é o que temos de realmente nosso, de impenetravelmente e inexpugnavelmente nosso” Fernando Pessoa iii Agradecimentos A Deus, pela vida. Aos meus pais simplesmente por tudo não há como citar ou descrever o que fizeram por mim ao longo desses 30 anos. Agradeço ao Guilherme, pelo carinho e apoio incondicional para que eu fizesse esse doutorado, que tornou a minha vida mais leve e radiante. A você um beijo bom.
    [Show full text]
  • Bioprocesso, Purificação E Caracterização Das Peptidases Produzidas Pelos Fungos Eupenicillium Javanicum E Myceliophthora Th
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE CIÊNCIAS FARMACÊUTICAS DE RIBEIRÃO PRETO Bioprocesso, purificação e caracterização das peptidases produzidas pelos fungos Eupenicillium javanicum e Myceliophthora thermophila e avaliação da produção de peptídeos biologicamente ativos Youssef Ali Abou Hamin Neto Ribeirão Preto 2017 UNIVERSIDADE DE SÃO PAULO FACULDADE DE CIÊNCIAS FARMACÊUTICAS DE RIBEIRÃO PRETO Bioprocesso, purificação e caracterização das peptidases produzidas pelos fungos Eupenicillium javanicum e Myceliophthora thermophila e avaliação da produção de peptídeos biologicamente ativos Tese de Doutorado apresentada ao Programa de Pós-Graduação em Ciências Farmacêuticas para obtenção do Título de Doutor em Ciências Área de Concentração: Produtos Naturais e Sintéticos. Orientado: Youssef Ali Abou Hamin Neto Orientador: Prof. Dr. Hamilton Cabral Versão corrigida da Tese de Doutorado apresentado ao apresentada ao Programa de Pós-Graduação em Ciências Farmacêuticas em 29/03/2017. A versão original encontra-se disponível na Faculdade de Ciências Farmacêuticas de Ribeirão Preto/USP. Ribeirão Preto 2017 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. Hamin Neto, Youssef Ali Abou Bioprocesso, purificação e caracterização das peptidases produzidas pelos fungos Eupenicillium javanicum e Myceliophthora thermophila e avaliação da produção de peptídeos biologicamente ativos. Ribeirão Preto, 2017. 193 p.; 30cm. Tese de Doutorado,
    [Show full text]
  • CARACTERIZAÇÃO ESTRUTURAL E FUNCIONAL DE21 UMA PROTEÍNA ISOLADA DO PLASMA DE SERPENTES21 Bothrops Jararaca, RELACIONADA AO CININOGÊNIO DE MAMÍFEROS.21
    ANDRÉ LUIZ SANSON21 CARACTERIZAÇÃO ESTRUTURAL E FUNCIONAL DE21 UMA PROTEÍNA ISOLADA DO PLASMA DE SERPENTES21 Bothrops jararaca, RELACIONADA AO CININOGÊNIO DE MAMÍFEROS.21 Dissertação apresentada ao Programa de Pós-Graduação em Toxinologia do Instituto Butantan, para Obtenção do título de Mestre em Ciências São Paulo 2012 ANDRÉ LUIZ SANSON CARACTERIZAÇÃO ESTRUTURAL E FUNCIONAL DE UMA PROTEÍNA ISOLADA DO PLASMA DE SERPENTES Bothrops jararaca, RELACIONADA AO CININOGÊNIO DE MAMÍFEROS. Dissertação apresentada ao Programa de Pós-Graduação em Toxinologia do Instituto Butantan, para Obtenção do título de Mestre em Ciências Orientador: Luís Roberto de Camargo Gonçalves São Paulo 2012 FICHA CATALOGRÁFICA Sanson, André Luiz Caracterização estrutural e funcional de uma proteína isolada do plasma de serpentes Bothrops jararaca, relacionada ao cininogênio de alta massa molecular de mamíferos/ André Luiz Sanson; orientador Luís Roberto de Camargo Gonçalves São Paulo. 88 fls. : il. color. ; 30 cm. Dissertação (Mestrado) – Programa de Pós-Graduação em Toxinologia, Instituto Butantan, 2012. 1. Espectrometria de Massas. 2. Purificação de proteínas. 3. Serpentes 4. Cininogênio. 5. Calicreína. I. Orientador (Camargo Gonçalves, Luís.). II. Programa de Pós-Graduação em Toxinologia. Instituto Butantan. III. Caracterização estrutural e funcional de uma proteína isolada do plasma de serpentes Bothrops jararaca, relacionada ao cininogênio de alta massa molecular de mamíferos. CDD 615.9 Elaborada com instruções fornecidas pela Biblioteca do Instituto Butantan Eu André Luiz Sanson, através desta declaração autorizo a divulgação da tese, por mídia impressa, eletrônica ou outra qualquer, após defesa. De acordo:__________________________________ Luís Roberto de Camargo Gonçalves Orientador Dedico este trabalho Aos meus pais, Osvaldo e Maria Luiza, pelo carinho, amor e compreensão..
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Natalia Da Ponte Leguizamón Unesp
    UNESP - Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Odontologia de Araraquara ! ! ! ! ! NATALIA DA PONTE LEGUIZAMÓN AVALIAÇÃO DO EFEITO DE FITOCISTATINAS SOBRE A EXPRESSÃO GÉNICA DE CATEPSINAS E CITOCINAS PRÓ-INFLAMATÓRIAS EM CÉLULAS RAW 264.7 DE CAMUNDONGOS E SOBRE A PRODUÇÃO DE TNF-a EM RATOS Araraquara 2017 UNESP - Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Odontologia de Araraquara ! ! ! ! ! NATALIA DA PONTE LEGUIZAMÓN AVALIAÇÃO DO EFEITO DE FITOCISTATINAS SOBRE A EXPRESSÃO GÉNICA DE CATEPSINAS E CITOCINAS PRÓ-INFLAMATÓRIAS EM CÉLULAS RAW 264.7 DE CAMUNDONGOS E SOBRE A PRODUÇÃO DE TNF-a EM RATOS Dissertação apresentada ao Programa de Pós- Graduação em Odontologia – Área de Periodontia, da Faculdade de Odontologia de Araraquara - Universidade Estadual Paulista, para a obtenção do título de Mestre. Orientador: Prof. Dr. Joni A. Cirelli Co-orientador: Michel L. de Campos Araraquara 2017 NATALIA DA PONTE LEGUIZAMÓN AVALIAÇÃO DO EFEITO DE FITOCISTATINAS SOBRE A EXPRESSÃO GÉNICA DE CATEPSINAS E CITOCINAS PRÓ-INFLAMATÓRIAS EM CÉLULAS RAW 264.7 DE CAMUNDONGOS E SOBRE A PRODUÇÃO DE TNF-a EM RATOS Comissão julgadora Dissertação para obtenção do grau de Mestre Presidente e Orientador: Prof. Dr. Joni Augusto Cirelli 2o Examinador: Profa. Dra. Rosângela Gonçalves Peccinini 3o Examinador: Prof. Dr. Flavio Henrique Silva Araraquara, 20 de fevereiro de 2017. DADOS CURRICULARES Natalia Da Ponte Leguizamón Nascimento 24 de julho de 1986 Asunción, Paraguay Filiação Jorge Luis Da Ponte Gonzalez Maria Mercedes Leguizamón Zaván 2005-2010 Graduação em Odontologia Universidad Nacional de Asunción 2011-2013 Curso de Especialização em Reabilitação Oral Universidad Nacional de Asunción 2014 Curso de Didática Universitária Universidad Nacional de Asunción 2015-2017 Pos-Graduação em Periodontia Nivel mestrado Faculdade de Odontologia de Araraquara Universidade Estadual Paulista- UNESP DEDICATÓRIA A DEUS, por me orientar nos caminhos percorridos e porque ele faz as coisas acontecerem.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel Et Al
    USOO8561811 B2 (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel et al. (45) Date of Patent: Oct. 22, 2013 (54) SUBSTRATE FOR IMMOBILIZING (56) References Cited FUNCTIONAL SUBSTANCES AND METHOD FOR PREPARING THE SAME U.S. PATENT DOCUMENTS 3,952,053 A 4, 1976 Brown, Jr. et al. (71) Applicants: Christian Gert Bluchel, Singapore 4.415,663 A 1 1/1983 Symon et al. (SG); Yanmei Wang, Singapore (SG) 4,576,928 A 3, 1986 Tani et al. 4.915,839 A 4, 1990 Marinaccio et al. (72) Inventors: Christian Gert Bluchel, Singapore 6,946,527 B2 9, 2005 Lemke et al. (SG); Yanmei Wang, Singapore (SG) FOREIGN PATENT DOCUMENTS (73) Assignee: Temasek Polytechnic, Singapore (SG) CN 101596422 A 12/2009 JP 2253813 A 10, 1990 (*) Notice: Subject to any disclaimer, the term of this JP 2258006 A 10, 1990 patent is extended or adjusted under 35 WO O2O2585 A2 1, 2002 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS (21) Appl. No.: 13/837,254 Inaternational Search Report for PCT/SG2011/000069 mailing date (22) Filed: Mar 15, 2013 of Apr. 12, 2011. Suen, Shing-Yi, et al. “Comparison of Ligand Density and Protein (65) Prior Publication Data Adsorption on Dye Affinity Membranes Using Difference Spacer Arms'. Separation Science and Technology, 35:1 (2000), pp. 69-87. US 2013/0210111A1 Aug. 15, 2013 Related U.S. Application Data Primary Examiner — Chester Barry (62) Division of application No. 13/580,055, filed as (74) Attorney, Agent, or Firm — Cantor Colburn LLP application No.
    [Show full text]